| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alpha-2 Adrenergic Receptor Agonists are Neuroprotective in Experimental Models of Glaucoma
|
Wheeler, L.A.
|
|
2001
|
|
2_suppl |
p. 30-35
|
artikel
|
| 2 |
Animal and Culture Models of Glaucoma for Studying Neuroprotection
|
Levin, L.A.
|
|
2001
|
|
2_suppl |
p. 23-29
|
artikel
|
| 3 |
Beta-Adrenergic Antagonists in the Treatment of Glaucoma
|
Gandolfi, S.A.
|
|
2001
|
|
2_suppl |
p. 63-66
|
artikel
|
| 4 |
Brimonidine (Alphagan®): A Clinical Profile Four Years after Launch
|
David, R.
|
|
2001
|
|
2_suppl |
p. 72-77
|
artikel
|
| 5 |
Brimonidine's Neuroprotective Effects against Transient Ischaemia-Induced Retinal Ganglion Cell Death
|
Vidal-Sanz, M.
|
|
2001
|
|
2_suppl |
p. 36-40
|
artikel
|
| 6 |
Electrophysiological Approaches for Early Detection of Glaucoma
|
Bach, M.
|
|
2001
|
|
2_suppl |
p. 41-49
|
artikel
|
| 7 |
Evaluation of Glaucomatous Visual Field Loss with Locally Condensed Grids Using Fundus-Oriented Perimetry (FOP)
|
Schiefer, U.
|
|
2001
|
|
2_suppl |
p. 57-62
|
artikel
|
| 8 |
Influence of Topical Brimonidine on Visual Field in Glaucoma
|
Lapuente, C. Ruiz
|
|
2001
|
|
2_suppl |
p. 67-71
|
artikel
|
| 9 |
Measuring Structural Changes in the Optic Nerve Head and Retinal Nerve Fibre Layer
|
Antón, A.
|
|
2001
|
|
2_suppl |
p. 50-56
|
artikel
|
| 10 |
Neuroprotection as a Treatment for Glaucoma: Pharmacological and Immunological Approaches
|
Schwartz, M.
|
|
2001
|
|
2_suppl |
p. 7-11
|
artikel
|
Tijdschrift beschrijving